在老年人中,Dyrk1b作为肉症的潜在生物标志物
Xin-Feng Jiao1, Guang-Jian Mu2, Wen-Ya Zhao2
1Department of Geriatrics, Affiliated Hospital of Nantong University, No.20 Xishi Road, Nantong, 226001, Jiangsu Province, China.
BMC geriatrics
|April 25, 2025
概括
低血清双重特异性氨酸调节激酶1b (Dyrk1b) 水平与老年人肉类的风险增加有关. Dyrk1b可以作为一种有价值的生物标志物来查和评估肉症.
科学领域:
- 老年学是一门学科.
- 生物化学 生物化学
- 肌肉生理学 肌肉生理学
背景情况:
- 随着年龄的增长而导致肌肉质量和功能丧失的萨尔科佩尼亚 (Sarcopenia) 构成了严重的健康挑战.
- 双重特异性氨酸调节激酶1b (Dyrk1b) 参与肌肉分化,但其在肉症中的作用尚不清楚.
研究的目的:
- 在社区居住的老年人中调查血清Dyrk1b水平和肉症之间的关联.
- 为了确定Dyrk1b是否可以作为肉类的生物标志物.
主要方法:
- 在939名老年人 (平均年龄76岁) 中测量了Dyrk1b血清水平.
- 使用尾骨肌肉质量指数 (ASMI),握力和步行速度来评估萨科佩尼亚.
- 与酶相关的免疫吸收试验 (ELISA) 用于测量Dyrk1b.
主要成果:
- 血清Dyrk1b水平在患有肉症的人群中明显低于没有肉症的人群 (P < 0.001).
- 血清Dyrk1b的切割值为44.73ppg/ml,预测了94.8%灵敏度 (AUC = 0.577) 的肉症.
- 较高的血清Dyrk1b水平与ASMI,握力和步行速度正相关,并与低 Sarcopenia 风险相关 (aOR = 0.342).
结论:
- 低血清Dyrk1b水平与老年人肉类的风险增加有关.
- Dyrk1b显示出作为一种替代性生物标志物,用于 Sarcopenia 查和评估的潜力.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


